Ad hoc and press releases

02/06/2012 Ad hoc release	Ad hoc release according to § 15 WpHG: STADA sells Irish production facility and thus continues to be in line with planning for the implementation of "STADA – build the future" More information

01/31/2012 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA: Purchase of a branded product portfolio for the EU markets in Central Europe successfully concluded More information

01/31/2012 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA: Purchase of a generics business in Switzerland successfully concluded More information

01/27/2012 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA and Grünenthal agreed on the purchase of a branded product portfolio also for the EU markets in Central Europe at a lower purchase price More information

01/01/2012 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA: Withdrawal from purchase of the Grünenthal branded product portfolio in Central Europe More information

12/30/2011 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA: Purchase of a branded product portfolio in Eastern Europe as well as in the Middle East successfully concluded – Central Europe still open More information

12/05/2011 Corporate News	STADA subsidiary increases commitment to charity More information

12/01/2011 Corporate News	STADA strengthens long-term refinancing with successful securing of promissory notes in the amount of EUR 400 million More information

11/23/2011 Corporate News	STADA sales companies very successful in large-volume 7th AOK tender in the German generics market More information

11/10/2011 Corporate News	STADA: Stabilization of business outlook in Serbia after letter of comfort from Serbian government More information

11/10/2011 Corporate News	STADA 1-9/2011: Good development of sales and operating earnings – High burden on reported key earnings figures through one-time special effects – Confirmation of long-term growth targets More information

11/09/2011 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA signs contract on the purchase of a generics business in Switzerland More information

10/31/2011 Corporate News	STADA sales companies very successful in tenders for discount agreements with various German public health insurance organizations More information

09/21/2011 Ad hoc release	Ad hoc release according to § 15 WpHG: STADA: Increased risk of default on outstanding receivables from Serbian pharmaceutical wholesalers leads to burdening one-time special effects of approx. EUR 97 million before taxes More information

08/30/2011 Corporate News	STADA and Richter cooperate for development of two biosimilar products for two monoclonal antibodies: Rituximab and Trastuzumab More information

08/11/2011 Corporate News	STADA: Positive business development in H1/2011 – Increase of Group sales and all key earnings figures – Outlook remains positive for 2011/2012 More information

08/01/2011 Corporate News	STADA sales companies achieve very good results in fourth DAK tender in the German generics market More information

07/22/2011 Ad hoc update	Ad hoc release according to § 15 WpHG: STADA and Grünenthal sign contracts on the purchase of a branded product portfolio in Central and Eastern Europe as well as the Middle East More information

06/16/2011 Corporate News	STADA AGM 2011: Executive Board continues to expect further growth in Group sales and earnings in 2011 and 2012 More information

05/26/2011 Corporate News	STADA acquires British branded product Cetraben^® for GBP 30 million (approx. EUR 34.6 million) More information

05/19/2011 Ad hoc release	Ad hoc release according to § 15 WpHG: STADA negotiating the purchase of a generics business in Switzerland More information

05/12/2011 Ad hoc release	Ad hoc release according to § 15 WpHG: STADA and Grünenthal in exclusive negotiations on the purchase of a branded product portfolio in Central and Eastern Europe as well as the Middle East for approx. EUR 360 million More information

05/12/2011 Corporate News	STADA: Positive business development in Q1/2011 – Increase of Group sales and all key earnings figures – Outlook remains positive for 2011/2012 More information

05/11/2011 Corporate News	STADA Group achieves strong result in 6th AOK tender in the German generics market More information

03/30/2011 Corporate News	STADA: Good operating results confirm successful financial year 2010 – positive outlook for 2011/2012 More information

02/28/2011 Ad hoc release	Ad hoc release according to § 15 WpHG: STADA: 2010 preliminary results confirm operationally successful year – dividend to amount to EUR 0.37 with unchanged distribution ratio – positive outlook for 2011/2012 More information

Management

Here you will find information regarding STADA Management and STADA Supervisory Board.

Share prices

The current STADA share price with share price chart including Excel download and market capitalization of STADA Arzneimittel AG are available here. We also offer you an interactive peer group share price comparison. More

Financial reports

Here you can read an online version of the last 4 financial reports on your screen, download the PDF or order a hard copy. Older financial reports are available in PDF format from our archive. More

Financial calendar

Don’t miss any publication or event! Have a look at our overview of all important financial events of STADA Arzneimittel AG for the current year and the next. More

Ad hoc and press releases

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG:

Ad hoc release according to § 15 WpHG: